Innovation1 Biotech Inc. (IVBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
May 9, 2025, 4:00 PM EDT
Innovation1 Biotech Balance Sheet
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '24 Feb 29, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2017 - 2018 |
| Cash & Equivalents | 0.11 | 0.05 | 0.16 | 0.14 | 0.02 | 0.02 | Upgrade
|
| Cash & Short-Term Investments | 0.11 | 0.05 | 0.16 | 0.14 | 0.02 | 0.02 | Upgrade
|
| Cash Growth | 104.91% | -68.14% | 13.83% | 668.84% | -5.76% | -97.55% | Upgrade
|
| Other Receivables | - | 0.01 | 0.06 | - | - | - | Upgrade
|
| Receivables | - | 0.01 | 0.06 | - | 0.13 | - | Upgrade
|
| Inventory | - | - | - | 0.02 | 0.04 | 0.2 | Upgrade
|
| Prepaid Expenses | 0.01 | 0.02 | 0.07 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Total Current Assets | 0.12 | 0.07 | 0.29 | 0.17 | 0.2 | 0.25 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0.48 | 0 | 0 | 0.01 | Upgrade
|
| Long-Term Investments | - | - | - | 0.01 | 0 | - | Upgrade
|
| Other Intangible Assets | 0 | 0 | 42.98 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | - | - | 0.21 | - | - | - | Upgrade
|
| Total Assets | 0.12 | 0.08 | 43.96 | 0.18 | 0.21 | 0.26 | Upgrade
|
| Accounts Payable | 0.35 | 0.35 | 0.11 | 0.04 | 0.44 | 0.05 | Upgrade
|
| Accrued Expenses | 0.29 | 1.18 | 0.16 | 0 | - | - | Upgrade
|
| Short-Term Debt | 0.05 | 0.01 | 0.01 | 0.16 | 0.84 | 0.08 | Upgrade
|
| Current Portion of Leases | - | - | 0.2 | - | - | - | Upgrade
|
| Other Current Liabilities | 2.21 | 1.75 | 29.34 | 0.2 | 1.6 | 0.1 | Upgrade
|
| Total Current Liabilities | 2.9 | 3.29 | 29.81 | 0.41 | 2.89 | 0.22 | Upgrade
|
| Long-Term Debt | 0.56 | 0.22 | - | - | - | - | Upgrade
|
| Long-Term Leases | - | - | 0.3 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 11 | - | - | - | Upgrade
|
| Total Liabilities | 3.46 | 3.51 | 41.11 | 0.41 | 2.89 | 0.22 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0 | 0 | 0.14 | Upgrade
|
| Additional Paid-In Capital | 56.2 | 55.17 | 47.38 | 2.75 | 1.16 | 0.94 | Upgrade
|
| Retained Earnings | -59.57 | -58.63 | -44.55 | -2.97 | -3.84 | -1.21 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | 0.16 | Upgrade
|
| Total Common Equity | -3.35 | -3.44 | 2.84 | -0.23 | -2.69 | 0.02 | Upgrade
|
| Shareholders' Equity | -3.34 | -3.43 | 2.85 | -0.22 | -2.68 | 0.03 | Upgrade
|
| Total Liabilities & Equity | 0.12 | 0.08 | 43.96 | 0.18 | 0.21 | 0.26 | Upgrade
|
| Total Debt | 0.61 | 0.23 | 0.51 | 0.16 | 0.84 | 0.08 | Upgrade
|
| Net Cash (Debt) | -0.5 | -0.18 | -0.35 | -0.02 | -0.82 | -0.06 | Upgrade
|
| Net Cash Per Share | -0.02 | -0.01 | -0.02 | -0.12 | -2.74 | -0.13 | Upgrade
|
| Filing Date Shares Outstanding | 22.47 | 22.47 | 20.02 | 20.02 | 0.19 | 0.44 | Upgrade
|
| Total Common Shares Outstanding | 22.47 | 20.47 | 20.02 | 0.19 | 0.19 | 0.44 | Upgrade
|
| Working Capital | -2.79 | -3.21 | -29.53 | -0.24 | -2.68 | 0.02 | Upgrade
|
| Book Value Per Share | -0.15 | -0.17 | 0.14 | -1.21 | -14.36 | 0.05 | Upgrade
|
| Tangible Book Value | -3.35 | -3.44 | -40.14 | -0.23 | -2.69 | 0.02 | Upgrade
|
| Tangible Book Value Per Share | -0.15 | -0.17 | -2.00 | -1.22 | -14.37 | 0.05 | Upgrade
|
| Machinery | - | - | - | - | 0 | 0.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.